As tirzepatide leaves your system, its glucose-lowering effects will diminish, and blood sugar levels may rise toward pre-treatment values
Rybelsus (semaglutide) is FDA-approved to treat type 2 diabetes, but some providers also prescribe it off label to support weight loss
Each pen contains only one dose and is discarded after use
These cases remain in active pretrial proceedings, where the parties are expected to address discovery, scientific evidence, expert testimony, case-specific injury proof, and the adequacy of manufacturer warnings
Patients who discontinued tirzepatide due to planned pregnancy should inform their obstetric provider, as the medication should be stopped at least 1 month before a planned conception according to FDA labeling